- The H.E.A.T. Formula
- Posts
- Are We Close to a Trade Deal With China?
Are We Close to a Trade Deal With China?
The š„H.E.A.T.š„ Formula : AI Driven Insights to Spark Your Portfolio

In Todayās Issue:
Launching 2x GME and 2x SNOW
Louis Navellier on the Rebel Podcast
Trumpās Plan for the Economy and How it Impacts Your Investments Today
Why this market is so tough
Are we close to a trade deal with China?
Why low volatility ETFs suck
Deep dive on Agentic AI
and moreā¦ā¦..
Announcements
Today we launch 2x GME (GMEU) and 2x SNOW (SNOU)
At 11:30AM EST the Rebel Finance Podcast will have Louis Navellier as our guest. Anyone old like me will remember Louis.
Our Webinar is Also Today
Trumpās Plan For the Economy and How It Impacts Your Investments
Thursday April 24, 2-3pm EST
News & Noise
š§ News:
"This market is tradable, but youāve got to have a lot of patience," @TuttleCapital says on Market On Close with @Cline_Woods.
Plus, he shares what could help traders navigate the wild swings.
ā Schwab Network (@SchwabNetwork)
8:01 PM ⢠Apr 22, 2025

Credit to @Vivek4real_ with the clip
ā Anthony Pompliano šŖ (@APompliano)
12:52 AM ⢠Apr 24, 2025
ā Noise:
What Wall Street Is Saying

We are going to have a lot more to say about this deal, stay tuned.
Mike OāRourke, Jones Tradingā¦..
One has to wonder why Xi Jinping would even come to the table at this juncture. Xi does not have to worry about the stock market, midterm elections, appropriating stimulus, and he is his own Jay Powell. All of these tariff ādevelopmentsā are occurring while China has maintained the simple position that it will āfight to the end.ā Treasury Secretary Bessentās comments yesterday that the trade situation with China is āunsustainableā and equates to an āembargoā has fueled equity strength with the expectation that the Trump Administration would be forced to fold its hand.
Mohit Kumar, Jefferiesā¦..
Reports suggest that Trump administration is looking at tariffs in the range of 50% - 65% for China with 35% for non-critical imports and 100% on imports that are deemed critical for national security. In our view, the numbers are far from the point which would be acceptable to China.
Jefferies Daily Macroā¦.
From a market perspective, our strategy has been to use rallies to reduce US exposure and yesterday was one of those days. Our medium-term view remains to use any rallies to reduce US exposure and use any sell-offs to add to Europe and Asia.
UBS Equity Strategyā¦..
The market is pricing toward a recessionary regime (33% recent peak in our models). Our framework leans into this with an ongoing preference for defensives over discretionary.
Are We Close to a Trade Deal With China?
*BESSENT: FULL CHINA TRADE DEAL MAY TAKE 2-TO-3 YEARS
*NO UNILATERAL OFFER FROM TRUMP TO CUT CHINA TARIFFS
ā Geiger Capital (@Geiger_Capital)
3:26 PM ⢠Apr 23, 2025
Tuesday night Trump came out and said that tariffs on China will be less than what had previously been reported. Markets took it as capitulation by Trump, then today Bessent says the above. This caused markets to close way off the highs, but it was a rally day pretty much regardless of what happened.
Are we close to a deal or not? No idea. I continue to say I think the lows are in, I think this market is tradeable, but itās a pain in the ass.
Stuff like this is also a pain in the assā¦..
BREAKING: President Trump says he is NOT considering changes to automobile and auto part tariffs.
Just 1 hour ago, FT reported that President Trump will be exempting carmakers from some US tariffs.
Auto stocks have gone from green to red after hours.
ā The Kobeissi Letter (@KobeissiLetter)
10:03 PM ⢠Apr 23, 2025
I am continuing to slowly add equity exposure. I often compare investing to Blackjack and Poker, and in Blackjack I slowly ramp up my bet size when the dealer seems to have a run of going bust. Same deal here, as I said above, I do think the lows are in, and it looks like things are starting to turn bullish. I think a lot of that is because the main messaging is now coming from Bessent and not Lutnick or Navarroā¦.
Daily S&P 500 returns depending on which Trump Administration official is speaking.
ā The Kobeissi Letter (@KobeissiLetter)
9:00 PM ⢠Apr 23, 2025
However, we are nowhere near being able to say the odds are in your favor to go long in any size.
Gold is back up this morning, Treasuries are up, and Bitcoin is selling off a drop. My main focus is still in those three areas.
GOOGL kicks off Mag 7 earnings tonight.
Are Low Volatility ETFs a Smart Long-Term Bet?
Had CNBC on in the background the other day and they couldnāt stop gushing about low volatility ETFs. Low volatility is a factor, something along with some other factors ā-momentum, quality, value, etc that was discovered in research to have outperformed the market over time. Iām not a fan of factor investing, primarily because I think once Wall Street discovers and edge then it gets arbed out and is no longer an edge. I had GPT take a deeper dive on low volatilityā¦ā¦.
š The Narrative: Low Volatility ETFs Are Having Their Moment
In 2025, low volatility ETFs like $SPLV and $USMV have been outperforming broader market cap-weighted benchmarks. Why? Because:
They hold tariff-insulated, domestic-facing stocks
They avoid much of the Magnificent 7 (which are more exposed to AI capex cycles and global trade uncertainty)
Investors are rotating defensively amid volatility, trade war risk, and Fed drama
But here's the problem: Theyāve massively underperformed over longer timeframes.
š§Ø Low Volatility ETFs ā What Are They, Really?
Low volatility ETFs track baskets of stocks with historically lower price fluctuations, typically measured via standard deviation. These ETFs include:
$SPLV (Invesco S&P 500 Low Volatility ETF)
$USMV (iShares MSCI USA Minimum Volatility ETF)
$XMLV, $EFAV, $XSLV and others across geographies and sectors
They tend to be:
Overweight utilities, staples, healthcare, REITs
Underweight tech, discretionary, communication services
Lower beta and lower drawdowns, but also lower upside participation
š 2025 YTD Snapshot: Low Volatility Winning
Vol-sensitive traders are seeking shelter from tariff noise and Powell-Trump chaos
These ETFs are less exposed to global cyclicals, semis, and China-sensitive megacaps
š§ But the Long-Term? Low Vol Has Lagged
Over the past 10 years:
$SPLV has underperformed SPY by nearly 50% cumulatively
Sharpe ratios are often lower than expected due to performance drag in bull markets
They tend to lag in growth-driven environments, reflation cycles, and innovation booms
š The Real Problem: Factor Arbitrage
"Once a factor is discovered and widely adopted, the alpha gets arbed out." ā Matt Tuttle
Low volatility used to be an obscure anomaly. Now itās a $50B+ asset class. Factor investors, quant funds, and retail allocators have piled in.
This inflows=alpha decay dynamic has:
Compressed the valuation edge
Crowded the trade (especially in defensive sectors)
Made it more sensitive to macro sentiment shifts and interest rate cycles
Once "low vol" becomes consensus, it starts acting more like a bond proxy than an alpha source.
š So What Do We Do?
š Tactical Suggestions:
Use Low Volatility ETFs for Short-Term Defense Only
Great for uncertain macro regimes (like 2025)
But treat them as trades, not long-term allocations
Overlay With Tail Risk or Smart Beta Hedges
Add ARKK or QQQ puts to protect against equity shocks
Combine with gold, Bitcoin, or commodities as structural hedges
Replace With Quality + Value + Low Debt Screens
Instead of blindly chasing low vol, build custom baskets of:
High free cash flow
Low debt-to-equity
Domestic-revenue-heavy stocks
Avoid heavy bond proxy exposure
Long/Short Low Vol vs High Beta Pairs
Consider a factor rotation play:
Long $SPLV, short $SPHB when vol is rising
Reverse that in soft-landing or reflation environments
Revisit When Macro Shifts
If rate volatility collapses and risk appetite returns, low vol will lag hard
Be ready to pivot back to cyclicals, AI, and global growth
š Final Word: Low Volatility Isn't a Hedge. It's a Trade.
If you're buying $SPLV or $USMV thinking you're being defensive and smart, you might just be buying a different type of beta.
Use it when the odds are in your favor. Fold when theyāre not.
The best strategy in a high-vol, policy-fractured market? Flexibility.
AI Agents and the Intelligent Software Economy
ARK just wrote a report on AI agents, an area of great interest to me and one where we have an ETF coming soon.
One of the powerful uses of AI is to have it analyze research reports like this, provide take aways, and create watch lists, so I fed it into GPT and had it analyze this reportā¦.
š¤ ARK's Bold Take: AI Agents Will Reshape Everything
ARK's latest research lays out a sweeping thesis: AI agents aren't just another layer on top of softwareāthey're a full-blown paradigm shift. Think cloud computing in 2007. Think smartphones in 2010. AI agents could have that kind of impact across enterprise software, consumer applications, and R&D workflows.
ARK defines AI agents as autonomous systems capable of:
Interpreting natural language
Independently reasoning and executing tasks
Continuously learning and adapting
The economic implications? Massive. ARK suggests we could see the largest software reinvention since the cloud.
š Where We Agree
1. Enterprise AI Agents Will Replace "One-Size-Fits-None" Software
ARK highlights Palantir (PLTR) as the poster child for customizable enterprise AI platforms. We agree. AIP is already helping governments and corporations build internal agents that automate logistics, detect fraud, and model risk. This isnāt future stateāitās happening now.
2. Agent-Based Consumer Apps Are Inevitable
From Shopify (SHOP) to Klarna, AI agents that combine search, recommendation, and execution are making old-school apps look clunky. The migration from static apps to proactive digital assistants is just beginning.
3. Scientific Discovery Will Be the Next Frontier
Biotech and drug discovery are ripe for AI agents. Companies like Recursion (RXRX) and Absci (ABSI) are already redefining the speed and cost of drug development. ARK is right: traditional pharma is getting left behind.
š Winners and Losers: Ranked 1ā10
š Top Winners: (10 = massive AI agent upside)
Rank | Ticker | Company | Score | Why It Wins |
---|---|---|---|---|
1 | RXRX | Recursion | 10 | AI-native biotech. Running billions of biological simulations with NVIDIA + Roche backing. Just merged with Exscientia. |
2 | PLTR | Palantir | 9.5 | Government and enterprise OS for agents. Deep data integration + workflow AI. First-mover advantage. |
3 | ABSI | Absci | 9.0 | Zero-shot antibody design = faster, cheaper, better drug discovery. Potential to leapfrog Big Pharma. |
4 | GTLB | GitLab | 8.5 | AI-native DevOps platform. Agents already coding, debugging, and testing autonomously. |
5 | SHOP | Shopify | 8.0 | Integrating AI search + transactions via Perplexity + Shop Pay. Enabling autonomous e-commerce. |
6 | TEM | Tempus AI | 7.5 | AI in diagnostics + clinical trials. Verticalized medical data = durable moat. Recent IPO adds visibility. |
7 | OPENAI (private) | OpenAI | 7.5 | Dominant in agent framework APIs. ChatGPT + dev ecosystem = viral data flywheel. |
8 | EXAI | Exscientia | 7.0 | AI chemistry + modeling platform. Now merged with Recursion. Synergy unlocks new scale. |
9 | COIN | Coinbase | 6.5 | Leader in integrating AI-driven interfaces into crypto trading + custody. Benefits from agent-based financial autonomy. |
10 | Klarna (private) | Klarna | 6.0 | Shopping agents tied to LLMs. Early mover in AI + fintech convergence. |
ā Potential Losers
Company | Why It Falls Behind |
SAP / ORCL | Traditional ERP software lacks agentic architecture. Slow to innovate, vulnerable to PLTR-style disruption. |
Legacy Pharma (PFE, MRK) | Too slow to pivot to AI-native drug discovery. Will likely license from RXRX/ABSI vs build in-house. |
Old-school consumer apps | Clunky UX, fragmented functionality, no proactive intelligence. Agents will cannibalize this space fast. |
š Monetization Models to Watch
Agent-as-a-Service (AaaS): Subscriptions with usage-based overages (Replit-style)
Autonomous Commerce: Agents complete transactions on your behalf (e.g., travel, groceries, investing)
Agent Marketplaces: Think App Store for intelligent tasks and workflows
These will reshape everything from SaaS pricing to e-commerce to enterprise licensing.
š Takeaway
AI agents arenāt an extension of software. They are a replacement.
They will redefine what software means in every vertical
Investors should focus on AI-native platforms (not incumbents trying to bolt on LLMs)
Biotech, enterprise, and consumer commerce will be the early monetization zones
If the cloud unlocked scale, AI agents will unlock autonomy.
Before you go: Here are ways I can help
ā
ETFs: We offer innovative ETFs that cover all aspects of The H.E.A.T. Formula, Hedges, Edges, and Themes.
Consulting: I'm happy to jump on the phone with financial advisors at no charge. I've built a wealth management firm and helped other advisors grow their practices through the use of substantially differentiated investment strategies. If you want to talk just send me an email at [email protected]
Monthly investing webinars
Rebel Finance Podcast https://www.youtube.com/@TuttleCap
Wealth Management-Coming Soon
Paid Newsletter Service-Coming Soon
The views and opinions expressed herein are those of the Chief Executive Officer and Portfolio Manager for Tuttle Capital Management (TCM) and are subject to change without notice. The data and information provided is derived from sources deemed to be reliable but we cannot guarantee its accuracy. Investing in securities is subject to risk including the possible loss of principal. Trade notifications are for informational purposes only. TCM offers fully transparent ETFs and provides trade information for all actively managed ETFs. TCM's statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. Trade notification files are not provided until full trade execution at the end of a trading day. The time stamp of the email is the time of file upload and not necessarily the exact time of the trades. TCM is not a commodity trading advisor and content provided regarding commodity interests is for informational purposes only and should not be construed as a recommendation. Investment recommendations for any securities or product may be made only after a comprehensive suitability review of the investorās financial situation.Ā© 2025 Tuttle Capital Management, LLC (TCM). TCM is a SEC-Registered Investment Adviser. All rights reserved.